- Home
- ORMP vs FBIO Comparison
ORMP vs FBIO Comparison
Compare ORMP & FBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORMP
- FBIO
- Stock Information
- Founded
- ORMP 2002
- FBIO 2006
- Country
- ORMP United States
- FBIO United States
- Employees
- ORMP N/A
- FBIO N/A
- Industry
- ORMP Biotechnology: Pharmaceutical Preparations
- FBIO Biotechnology: Pharmaceutical Preparations
- Sector
- ORMP Health Care
- FBIO Health Care
- Exchange
- ORMP Nasdaq
- FBIO Nasdaq
- Market Cap
- ORMP 104.6M
- FBIO 88.7M
- IPO Year
- ORMP N/A
- FBIO N/A
- Fundamental
- Price
- ORMP $2.43
- FBIO $3.11
- Analyst Decision
- ORMP
- FBIO Strong Buy
- Analyst Count
- ORMP 0
- FBIO 2
- Target Price
- ORMP N/A
- FBIO $16.50
- AVG Volume (30 Days)
- ORMP 120.6K
- FBIO 1.6M
- Earning Date
- ORMP 11-06-2025
- FBIO 11-13-2025
- Dividend Yield
- ORMP N/A
- FBIO N/A
- EPS Growth
- ORMP N/A
- FBIO N/A
- EPS
- ORMP N/A
- FBIO N/A
- Revenue
- ORMP $2,000,000.00
- FBIO $59,301,000.00
- Revenue This Year
- ORMP N/A
- FBIO $49.84
- Revenue Next Year
- ORMP N/A
- FBIO $42.47
- P/E Ratio
- ORMP N/A
- FBIO N/A
- Revenue Growth
- ORMP N/A
- FBIO N/A
- 52 Week Low
- ORMP $1.82
- FBIO $1.33
- 52 Week High
- ORMP $3.09
- FBIO $4.20
- Technical
- Relative Strength Index (RSI)
- ORMP 53.62
- FBIO 46.19
- Support Level
- ORMP $2.37
- FBIO $2.72
- Resistance Level
- ORMP $2.57
- FBIO $4.01
- Average True Range (ATR)
- ORMP 0.15
- FBIO 0.30
- MACD
- ORMP -0.01
- FBIO -0.11
- Stochastic Oscillator
- ORMP 37.00
- FBIO 25.00
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.
About FBIO Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.